FreMon Scientific

FreMon Scientific

Growth Stage

Plasma thawing products

Plasma thawing products

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

Netcapital

Start Date

01/27/2022

Close Date

04/29/2022

Min. Goal
$10,008
Max. Goal
$1,069,996
Min. Investment

$101

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$11.27

Pre-Money Valuation

$38,190,807

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

04/29/2022

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2013

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B

Margin

Low

Capital Intensity

High

Location

San Diego, California

Business Type

Growth

FreMon Scientific, with a valuation of $38.1 million, is raising funds on NetCapital. The company has developed, patented, and commercialized a blood product warming and thawing technology. The device is called ZipThaw202 with ZipSleeve and helps clinicians and lab technicians in plasma thawing. FreMon Scientific’s product is FDA cleared, certified under the American Association of Blood Banks, and sold in more than 14 countries and territories. Farideh Z. Bischoff, Frederick J. Thacher, and Menachem Shavit founded FreMon Scientific in April 2013. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,069,996. The campaign proceeds will be used for compensation, sales and marketing, inventory, manufacturing, and product development.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$225,814

$0

COGS

$494,139

$0

Tax

$0

$0

 

 

Net Income

$-4,673,626

$-3,808,739

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$485,191

$1,607,641

Accounts Receivable

$0

$0

Total Assets

$2,772,353

$2,090,786

Short-Term Debt

$5,500,000

$0

Long-Term Debt

$2,349,579

$4,830,000

Total Liabilities

$7,849,579

$4,830,000

Financials as of: 01/27/2022
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
FreMon Scientific on Netcapital 2022
Platform: Netcapital
Security Type: Equity - Common
Valuation: $38,190,807
Price per Share: $11.27

Follow company

Follow FreMon Scientific on Netcapital 2022

Buy FreMon Scientific's Deal Report

Warning: according to the close date for this deal, FreMon Scientific may no longer be accepting investments.

FreMon Scientific Deal Report

Get KingsCrowd’s comprehensive report on FreMon Scientific including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether FreMon Scientific is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the FreMon Scientific deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge